Market Access
Market access that delivers
The most effective value demonstration closely aligns with the lived experiences of patients, payers, and clinicians in each market. For that reason, successful pricing and reimbursement outcomes are about far more than translating a global value story. Our dedicated pharmaceutical market access team follows a meticulous adaption process, assessing a medicine’s potential combined with the realities of market dynamics, payer incentives and competitor landscape to solidify your product’s market position and determine optimal pathways for pricing and reimbursement.
Market access strategy
Our tailored market access strategies capture critical regional nuances, securing optimal funding pathways and identifying risks along with mitigation tactics. We develop strategies that highlight your product’s strengths while formulating the evidence base and value proposition for the specific market. This approach culminates in comprehensive reimbursement dossiers that fully capitalise on the product’s value within the regional context.
HEOR
We aim to replace assumptions with real-world insights, ensuring that our health economic and outcomes research models reflect the experiences of patients, payers, and clinicians alike.
By accessing registries and aggregate-level patient data, we ensure that product value claims are accurately quantified and substantiated in the accompanying models.
Submission Management
As an international team of market access experts, we leverage our relationships to ensure our submissions meet all relevant expectations. Following submission, we work closely with review committees, ultimately leading the final negotiation of reimbursement conditions.
“We strive to achieve the best results for our clients, using the most up-to-date data and insights possible.”
Ready to take the next step?
Let us share how we could successfully support your product commercialisation.
